your market intelligence analyst
Search Results
325 results
Your search is now limited to «Drugs» expert search. 08/04/2020 09:26
However, these biomarker levels are also affected by obesity, age, kidney disease, severe infection, high blood pressure in the vessels that bring blood to the lungs (pulmonary hypertension), abnormal heart rhythms and a specific heart failure medication.
More from
Science Media Centre 08/03/2020 18:40
Prof Robert Storey, Professor of Cardiology, University of Sheffield, said: “There is a huge amount of evidence showing that LDL or ‘bad’ cholesterol is responsible, to a large extent, for the build-up of fat in the blood vessels supplying the heart, brain and other parts of the body ...
More from Science Media Centre:
Statins are routinely prescribed to people thought to be at risk of heart disease, including those with diabetes, high blood pressure and over-75s.
More from Mail on Sunday (United Kingdom):
FeedNavigator (EU) 08/03/2020 15:03
Discussion In this Swedish register-based cohort study of 62,557 individuals with hypertension in primary care, adding diabetes to hypertension was associated with 57% excess risk of mortality, 24% excess risk of myocardial infarction and 17% excess risk of ischemic stroke.
More from FeedNavigator (EU):
Business Wire 07/30/2020 08:00
The Impella RP is CE marked to treat right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, open-heart surgery, or refractory ventricular arrhythmia.
More from Business Wire:
PMLiVE 07/30/2020 07:19
Boehringer Ingelheim and Eli Lilly’s heart failure drug Jardiance reduced the risk of cardiovascular death or hospitalisation due to heart failure in adult patients with and without diabetes – an important milestone for the drug.
More from PMLiVE: 07/30/2020 07:17
Conditions : Coronary Disease; Platelet Aggregation Intervention : Diagnostic Test: VerifyNow PRUTest Sponsor : Accriva Diagnostics Completed.
More from
Pharmafile 07/30/2020 07:10
The pair revealed that the 10mg dose of the drug met its primary endpoint in a study of 3,630 participants, successfully reducing the risk of cardiovascular death or hospitalisation as a result of heart failure when used in combination with standard of care.
More from Pharmafile:
The program was tailored to the cardiac population with slight differences in the program depending on patients’ primary diagnosis (coronary artery disease, heart failure, and hypertension), as the preferred health behaviors may vary depending on the diagnosis.
More from Journal of Medical Internet Research: 07/28/2020 10:16
A large group of men with prostate cancer require management of hypertension.
More from (India) 07/26/2020 05:47
Additionally, the researchers examined epidemiological data and found that incidences of heart failure were significantly higher in hypertensive patients treated with LCCBs than in hypertensive patients treated with other types of hypertension medications.
More from (India):
ETHealthWorld (India) 07/26/2020 02:49
Paul B Yu, MD, PhD, a cardiovascular medicine specialist at Brigham and Women's Hospital, has been studying PAH for more than 15 years to better understand the fundamental process in which blood vessels in the lungs are lost to the disease.
More from ETHealthWorld (India):
PR Newswire 07/24/2020 19:36
SAN DIEGO, July 24, 2020 /PRNewswire/ -- MetVital, Inc., a privately held biopharmaceutical company developing small molecule modulators of altered glutamate metabolism for the treatment of diseases with significant unmet medical need and commercial potential, today announces that the...
More from PR Newswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications